DNA strand with tuberculosis bacteria and Andes Mountains

Unlocking TB Resistance: Can Our Genes Hold the Key?

Soraya Malik in Health & Wellness June 2025 • 4 min read.

"A Colombian study explores how genetic variations in immune-regulating genes might influence susceptibility to pulmonary tuberculosis, offering potential insights into novel prevention strategies."

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a major global health challenge. While environmental factors and access to healthcare play significant roles, our individual genetic makeup can also influence our susceptibility to the disease. Interferon-gamma (IFNy) is a vital component of our immune defense against Mtb, and variations in the genes that control its production may affect our ability to fight off infection.

New research is exploring how variants in the genes that code for IFNy transcription factors—specifically TBET, STAT1, STAT4, and HLX—might impact the risk of developing pulmonary TB. Researchers are focusing on a Colombian population to understand how genetic variations within these genes correlate with either increased susceptibility or resistance to TB.

This study delves into the intricate relationship between our genes and our body's natural defenses. By pinpointing genetic variants linked to TB resistance, researchers hope to open new avenues for developing targeted prevention strategies and personalized treatments.

Decoding the Genetic Puzzle: IFNy Transcription Factors and TB

DNA strand with tuberculosis bacteria and Andes Mountains

The study, a case-control study conducted in Colombia, involved analyzing eight candidate single-nucleotide polymorphisms (SNPs) in the TBET, STAT1, STAT4, and HLX genes. SNPs are variations in a single building block of DNA, and they can influence how genes function. The researchers genotyped 466 unrelated pulmonary TB patients and 300 healthy controls, then looked for associations between specific SNPs and TB status.

While most of the SNPs studied did not show a strong association with TB, one particular SNP in the TBET gene, rs11650354, showed a potential link to decreased TB risk. Specifically, individuals with the TT genotype for this SNP appeared to have a significantly lower risk of developing TB compared to those with other genotypes. However, it's important to note that this association didn't hold up after multiple test correction, meaning that further research is needed to confirm the finding.

TBET (T-box 21): Plays a key role in Th1 lymphocyte commitment, essential for immune response against intracellular pathogens like Mtb.
STAT1 (Signal Transducer and Activator of Transcription 1): Crucial for IFNy signaling, enabling cells to respond to immune signals.
STAT4 (Signal Transducer and Activator of Transcription 4): Mediates the effects of IL-12, promoting Th1 differentiation and IFNy production.
HLX (H2.0-like homeobox): A transcription factor involved in various developmental processes; its role in immune regulation is less defined but potentially significant.

The researchers suggest that the rs11650354 variant of TBET might promote resistance to TB in the Colombian population they studied. But they emphasize that this is just a starting point. More research with larger and more diverse populations is essential to validate this association and understand the underlying mechanisms.

The Road Ahead: Translating Genetic Insights into TB Prevention

This Colombian study provides a fascinating glimpse into the potential role of genetics in TB resistance. While the findings regarding the TBET gene are preliminary, they highlight the importance of exploring the complex interplay between our genes and our immune system in the fight against infectious diseases. Future research promises to uncover more of these genetic factors, potentially leading to personalized prevention strategies and more effective treatments for TB.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What is the connection between Interferon-gamma (IFNy) and resistance to pulmonary tuberculosis?

IFNy is a crucial part of the immune system's defense against Mycobacterium tuberculosis (Mtb), the bacteria that causes tuberculosis. Variations in the genes that control IFNy production can impact our ability to fight off the infection. This research explores how variants in the genes coding for IFNy transcription factors like TBET, STAT1, STAT4, and HLX might influence the risk of developing pulmonary TB. The study indicates that genetic variations in these genes might affect an individual's susceptibility or resistance to TB.

How do specific genes like TBET, STAT1, STAT4, and HLX influence TB susceptibility?

TBET, STAT1, STAT4, and HLX are genes that play key roles in immune function. TBET is essential for immune response against intracellular pathogens such as Mtb. STAT1 is crucial for IFNy signaling, which enables cells to respond to immune signals. STAT4 mediates the effects of IL-12, which promotes Th1 differentiation and IFNy production. HLX's role in immune regulation is less defined but potentially significant. The Colombian study investigated how variations in these genes, particularly single-nucleotide polymorphisms (SNPs), might be linked to either increased susceptibility or resistance to TB. These genes are involved in the complex interplay between our genes and our immune system, affecting our body's natural defenses.

What are single-nucleotide polymorphisms (SNPs) and why are they important in the context of this TB research?

SNPs are variations in a single building block of DNA. They are important because they can influence how genes function. The researchers in the Colombian study analyzed SNPs in the TBET, STAT1, STAT4, and HLX genes to see if any specific variations correlated with a higher or lower risk of developing pulmonary TB. By examining these SNPs, scientists aimed to understand how slight differences in our genetic code might affect our vulnerability to tuberculosis. The study examined eight candidate SNPs to find their association with TB status in the studied population.

What were the key findings regarding the TBET gene and its link to TB resistance?

The study found a potential link between a specific SNP (rs11650354) in the TBET gene and decreased TB risk. Individuals with the TT genotype for this SNP appeared to have a lower risk of developing TB. However, this association was not statistically significant after multiple test correction, meaning further research is needed to confirm the finding. TBET plays a key role in immune response against intracellular pathogens like Mtb, which makes the connection between this gene and TB resistance very interesting.

How can the insights from this study be used to develop new TB prevention strategies and treatments?

By pinpointing genetic variants linked to TB resistance, this research opens new avenues for personalized approaches to TB prevention and treatment. Identifying genetic factors like the TBET gene variant could lead to targeted prevention strategies. Although the findings regarding the TBET gene are preliminary, the study highlights the importance of further research to understand the complex interplay between our genes and our immune system in the fight against infectious diseases. Future research could uncover more genetic factors, potentially leading to more effective treatments and personalized approaches for TB.